Outset Medical OM Income Statement (2019-2026)

NASDAQ OM
$3.23 -0.08 (-2.42%)
As of: Sep 10, 2026 · 2:06 PM EDT
Reported Financials

Outset Medical Quarterly Income Statement

Periods 30 quarters
Latest Jun 2026

Outset Medical reported revenue of $31.64M and net income of -$17.98M for the quarter ended Jun 2026, up 0.7% year over year. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
26.32M28.15M30.55M25.06M27.76M32.01M33.47M36.04M30.36M30.51M28.17M27.39M28.67M29.47M29.75M31.42M29.43M28.87M27.86M31.64M
Cost of RevenueCost of Rev
23.37M24.83M26.11M21.27M23.43M26.73M27.04M28.34M23.20M22.80M19.95M17.61M18.85M18.72M18.69M19.55M17.84M16.64M15.77M18.35M
Gross Profit
2.95M3.32M4.44M3.78M4.34M5.27M6.43M7.70M7.16M7.71M8.21M9.78M9.82M10.75M11.07M11.87M11.59M12.23M12.10M13.28M
Operating items
Research & DevelopmentR&D
15.73M22.99M20.38M23.20M22.28M23.63M24.33M24.98M24.72M22.19M21.05M18.13M15.42M15.45M13.65M14.28M13.55M12.88M13.28M12.15M
Selling, General & AdministrativeSG&A
7.63M9.72M9.71M10.78M10.00M10.02M11.79M11.29M11.81M10.34M11.44M12.68M10.10M9.27M8.30M9.16M8.48M11.93M10.12M11.36M
Restructuring CostsRestructuring
2.70M1.40M1.50M
Other Operating ExpensesOther Opex
9.73M11.41M10.83M13.52M13.06M11.44M13.79M14.91M16.08M12.53M9.94M9.73M6.74M6.39M5.51M5.29M5.38M5.05M5.62M5.45M
Operating ExpensesOpex
33.08M44.12M40.92M47.50M45.34M45.10M49.91M51.18M52.61M45.06M45.13M40.55M33.66M32.61M27.46M28.73M27.40M29.86M29.01M28.96M
Operating IncomeOp. Inc
-30.14M-40.80M-36.48M-43.72M-41.00M-39.82M-43.48M-43.48M-45.45M-37.35M-36.91M-30.76M-23.84M-21.86M-16.40M-16.86M-15.81M-17.63M-16.92M-15.68M
EBIT
-30.14M-40.80M-36.48M-43.72M-41.00M-39.82M-43.48M-43.48M-45.45M-37.35M-36.91M-30.76M-23.84M-21.86M-16.40M-16.86M-15.81M-17.63M-16.92M-15.68M
Non-operating items
Non Operating Interest Expenses
0.43M0.43M0.42M0.48M0.57M2.10M2.94M3.10M3.21M3.42M5.97M6.01M6.07M5.83M3.56M3.48M3.48M3.44M3.37M3.44M
Interest & Investment IncomeInt & Inv Inc
-0.47M-0.31M0.45M-0.28M-0.33M-0.04M0.05M-0.04M-0.24M
Other Non Operating IncomeOther Non Op Inc.
-7.68M
Non Operating IncomeNon Op. Inc.
0.10M0.12M0.12M0.46M0.81M1.91M2.65M2.67M2.57M2.28M3.10M2.47M2.15M2.04M1.98M1.90M1.85M1.67M1.53M1.35M
Net income details
EBT
-30.47M-41.11M-36.78M-43.74M-40.76M-41.38M-43.78M-43.91M-46.09M-38.49M-39.78M-34.30M-27.76M-25.64M-25.67M-18.44M-17.43M-19.40M-18.76M-17.76M
Tax ProvisionsTaxes
0.12M0.12M0.10M0.02M0.06M0.19M0.13M0.09M0.11M0.16M0.15M0.18M-0.00M0.12M0.10M0.40M-17.62M0.22M0.22M
Profit After TaxPAT
-30.47M-41.23M-36.89M-43.84M-40.78M-41.49M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.66M-25.78M-18.54M-17.84M-19.50M-18.98M-17.98M
Income from Continuing OperationsIncome (Continuing)
-30.47M-41.23M-36.89M-43.84M-40.78M-41.44M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.64M-25.78M-18.54M-17.84M-1.78M-18.98M-17.98M
Consolidated Net IncomeConsol Net Inc.
-30.47M-41.23M-36.89M-43.84M-40.78M-41.44M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.64M-25.78M-18.54M-17.84M-1.78M-18.98M-17.98M
Income towards Parent CompanyParent Net Inc
-30.47M-41.23M-36.89M-43.84M-40.78M-41.44M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.64M-25.78M-18.54M-17.84M-1.78M-18.98M-17.98M
Net Income towards Common StockholdersNet Income
-30.47M-41.23M-36.89M-43.84M-40.78M-41.44M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.64M-25.78M-18.54M-17.84M-1.78M-18.98M-17.98M
Additional items
EPS (Basic)
-9.81-13.57-11.65-13.73-12.71-12.91-13.52-13.50-13.88-11.68-11.77-9.96-8.30-7.40-3.66-1.04-1.00-0.12-1.03-0.97
EPS (Diluted)
-9.81-13.57-11.65-13.73-12.71-12.91-13.52-13.50-13.88-11.68-11.77-9.96-8.30-7.40-3.66-1.04-1.00-0.12-1.03-0.97
Shares Outstanding
3.11M3.04M3.17M3.19M3.21M3.21M3.25M3.26M3.33M3.31M3.39M3.46M3.37M3.46M7.04M17.74M17.78M15.21M18.37M18.62M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
3.11M3.04M3.17M3.19M3.21M3.21M3.25M3.26M3.33M3.31M3.39M3.46M3.37M3.46M7.04M17.74M17.78M15.21M18.37M18.62M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
3.13M3.15M3.18M3.20M3.22M3.23M3.28M3.31M3.35M3.35M3.45M3.47M3.50M3.53M7.04M17.77M17.81M18.17M18.53M18.80M
EBITDA
-30.14M-40.80M-36.48M-43.72M-41.00M-39.82M-43.48M-43.48M-45.45M-37.35M-36.91M-30.76M-23.84M-21.86M-16.40M-16.86M-15.81M-17.63M-16.92M-15.68M
Interest ExpensesInt Expense
0.43M0.43M0.42M0.48M0.57M2.10M2.94M3.10M3.21M3.42M5.97M6.01M6.07M5.83M3.56M3.48M3.48M3.44M3.37M3.44M
Tax Rate
-0.30%-0.31%-0.22%-0.05%-0.15%-0.44%-0.30%-0.19%-0.29%-0.41%-0.44%-0.66%0.02%-0.45%-0.56%-2.32%90.84%-1.16%-1.24%